These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15347716)

  • 21. Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients.
    Schöder H; Erdi YE; Chao K; Gonen M; Larson SM; Yeung HW
    J Nucl Med; 2004 Apr; 45(4):559-66. PubMed ID: 15073250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiparametric analysis of bone marrow in cancer patients using simultaneous PET/MR imaging: Correlation of fat fraction, diffusivity, metabolic activity, and anthropometric data.
    Schraml C; Schmid M; Gatidis S; Schmidt H; la Fougère C; Nikolaou K; Schwenzer NF
    J Magn Reson Imaging; 2015 Oct; 42(4):1048-56. PubMed ID: 25683203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term precision of 18F-fluoride PET skeletal kinetic studies in the assessment of bone metabolism.
    Frost ML; Blake GM; Park-Holohan SJ; Cook GJ; Curran KM; Marsden PK; Fogelman I
    J Nucl Med; 2008 May; 49(5):700-7. PubMed ID: 18413385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of metastatic involvement in bone using anatomical and functional information from 18F-FDG PET/CT.
    Demirkaya O; AlQahtani M; Alsugair A; Aras O; Abouzied ME
    Nucl Med Commun; 2017 Sep; 38(9):780-787. PubMed ID: 28704338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simple quantification of skeletal muscle glucose utilization by static 18F-FDG PET.
    Yokoyama I; Inoue Y; Moritan T; Ohtomo K; Nagai R
    J Nucl Med; 2003 Oct; 44(10):1592-8. PubMed ID: 14530472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correcting tumour SUV for enhanced bone marrow uptake: retrospective 18F-FDG PET/CT studies.
    Teo BK; Badiee S; Hadi M; Lam T; Johnson L; Seo Y; Bacharach SL; Hasegawa BH; Franc BL
    Nucl Med Commun; 2008 Apr; 29(4):359-66. PubMed ID: 18317301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP).
    Specht JM; Tam SL; Kurland BF; Gralow JR; Livingston RB; Linden HM; Ellis GK; Schubert EK; Dunnwald LK; Mankoff DA
    Breast Cancer Res Treat; 2007 Sep; 105(1):87-94. PubMed ID: 17268819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of six quantitative methods for the measurement of bone turnover at the hip and lumbar spine using 18F-fluoride PET-CT.
    Puri T; Blake GM; Frost ML; Siddique M; Moore AE; Marsden PK; Cook GJ; Fogelman I; Curran KM
    Nucl Med Commun; 2012 Jun; 33(6):597-606. PubMed ID: 22441132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
    Chen W; Cloughesy T; Kamdar N; Satyamurthy N; Bergsneider M; Liau L; Mischel P; Czernin J; Phelps ME; Silverman DH
    J Nucl Med; 2005 Jun; 46(6):945-52. PubMed ID: 15937304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma.
    Ma BB; King A; Lo YM; Yau YY; Zee B; Hui EP; Leung SF; Mo F; Kam MK; Ahuja A; Kwan WH; Chan AT
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):714-20. PubMed ID: 17011447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of Skeletal Tumor Burden on 18F-Fluoride PET/CT.
    Rohren EM; Etchebehere EC; Araujo JC; Hobbs BP; Swanston NM; Everding M; Moody T; Macapinlac HA
    J Nucl Med; 2015 Oct; 56(10):1507-12. PubMed ID: 26135112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Standardized Uptake Values in Normal Structures Between PET/CT and PET/MRI in a Tertiary Pediatric Hospital: A Prospective Study.
    Lyons K; Seghers V; Sorensen JI; Zhang W; Paldino MJ; Krishnamurthy R; Rohren EM
    AJR Am J Roentgenol; 2015 Nov; 205(5):1094-101. PubMed ID: 26496558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
    Hustinx R; Lemaire C; Jerusalem G; Moreau P; Cataldo D; Duysinx B; Aerts J; Fassotte MF; Foidart J; Luxen A
    J Nucl Med; 2003 Apr; 44(4):533-9. PubMed ID: 12679396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSF.
    Doot RK; Dunnwald LK; Schubert EK; Muzi M; Peterson LM; Kinahan PE; Kurland BF; Mankoff DA
    J Nucl Med; 2007 Jun; 48(6):920-5. PubMed ID: 17504870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 18F-fluoride PET/CT for bone scanning. Role of attenuation correction.
    Nagarajah J; Dannat T; Hartung V; Bockisch A; Rosenbaum-Krumme S
    Nuklearmedizin; 2012; 51(3):84-7. PubMed ID: 22366817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in sodium fluoride-18 uptake in the normal skeleton depending on the location and characteristics of the bone.
    Nawata S; Kaneta T; Ogawa M; Ishiwata Y; Kobayashi N; Shishikura-Hino A; Yoshida K; Inaba Y; Saito T; Inoue T
    Nuklearmedizin; 2017 Jun; 56(3):91-96. PubMed ID: 28488727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic PET-CT studies for characterizing nasopharyngeal carcinoma metabolism: comparison of analytical methods.
    Huang B; Khong PL; Kwong DL; Hung B; Wong CS; Wong CY
    Nucl Med Commun; 2012 Feb; 33(2):191-7. PubMed ID: 22107997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of methods to quantitate 18F-FDG uptake with PET during experimental acute lung injury.
    Chen DL; Mintun MA; Schuster DP
    J Nucl Med; 2004 Sep; 45(9):1583-90. PubMed ID: 15347728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adrenal masses in patients with cancer: PET/CT characterization with combined CT histogram and standardized uptake value PET analysis.
    Perri M; Erba P; Volterrani D; Guidoccio F; Lazzeri E; Caramella D; Mariani G
    AJR Am J Roentgenol; 2011 Jul; 197(1):209-16. PubMed ID: 21701032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allogenic bone graft viability after hip revision arthroplasty assessed by dynamic [18F]fluoride ion positron emission tomography.
    Piert M; Winter E; Becker GA; Bilger K; Machulla H; Müller-Schauenburg W; Bares R; Becker HD
    Eur J Nucl Med; 1999 Jun; 26(6):615-24. PubMed ID: 10369947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.